本報告已在2011年07月19日停止出版。
Abstract
Research Overview
Rising Prevalence of Cancer in Europe Creates Need for Advanced Diagnostics Enabling Early Detection
Immunohistochemistry (IHC) has emerged as an important tool for cancer diagnostics due to the growing appeal of new molecular diagnostic tests that can detect cancer in its earliest stages or even predict one�fs predisposition to the disease. The success of recent campaigns in Europe in improving patient management by encouraging people to be screened for certain subtypes of cancer suggests that the primary focus of IHC diagnostic testing should be on early disease detection and treatment. Cancers of the breast, prostate as well as colon are particularly responsive to early detection and treatment, yielding significantly higher survival rates as a result. Timely detection also helps decrease the need for expensive therapies, invasive procedures and potentially harmful imaging techniques, which in turn, reduce bed occupancy rates as well as the overall burden on the healthcare system. These factors are together driving governments to implement national cancer screening programmes.
This Frost & Sullivan research service provides a comprehensive analysis of the European immunohistochemistry diagnostics market. It examines the business potential for this market in Europe, taking into account industry dynamics and drivers in each region. It also provides an overview of the market�fs attractiveness, which can be very helpful to companies interested in entering the market or increasing their presence.
Cancer Testing Becomes Easier with Improved Automated Diagnostic Techniques
The antibodies used to detect cancer today are increasingly specific and sensitive and the analysers available in the market are faster and easier to use than ever before. Due to advancements in automation, the technical performance of assays has improved substantially, which has helped reduced the total assay time as well as the overall costs of reagents. "Over the next three years, these technological improvements are expected to result in faster turnaround times, higher throughput and enhanced ease of use, which in turn, is likely to increase the demand for IHC tests," says the analyst of this research service.
Higher accuracy of tests can increase the levels of expertise and skills, allowing for technological innovations and leading to reduced complexities within research and development (R&D). Additionally, it can provide access to greater R&D capacity as well as to therapeutic expertise, thereby bringing about alignment with diagnostic tests for safer and more effective therapies.
Table Of Contents
1. EXECUTIVE SUMMARY
Executive Summary
2. GLOSSARY TERMS AND EXCHANGE RATES
Glossary of Terms and Exchange Rates
- 1. Glossary of Terms
- 2. Exchange Rates
3. INDUSTRY CHALLENGES
Identification of the Challenges Facing the European Immunohistochemistry Diagnostics Market
4. EUROPEAN IMMUNOHISTOCHEMISTRY DIAGNOSTICS MARKET
Forecast of the European Immunohistochemistry Diagnostics Market
- 1. Introduction and Background
- 2. Research and Methodology
- 3. Market Segmentation
- 4. Research Measurement
- 5. Market Drivers
- 6. Revenue Forecasts
- 7. Pricing Trends
- 8. Technology Trends
- 9. End-user Trends
- 10. Geographic Trends
- 11. Competitive Structure
5. GERMAN IMMUNOHISTOCHEMISTRY DIAGNOSTICS MARKET
Forecast of the German Immunohistochemistry Diagnostics Market
- 1. Market Overview
- 2. Research Measurement
- 3. Revenue Forecasts
- 4. Competitive Structure
6. FRENCH IMMUNOHISTOCHEMISTRY DIAGNOSTICS MARKET
Forecast of the French Immunohistochemistry Diagnostics Market
- 1. Market Overview
- 2. Research Measurement
- 3. Revenue Forecasts
- 4. Competitive Structure
7. ITALIAN IMMUNOHISTOCHEMISTRY DIAGNOSTICS MARKET
Forecast of the Italian Immunohistochemistry Diagnostics Market
- 1. Market Overview
- 2. Research Measurement
- 3. Revenue Forecasts
- 4. Competitive Structure
8. UK IMMUNOHISTOCHEMISTRY DIAGNOSTICS MARKET
Forecast of the UK Immunohistochemistry Diagnostics Market
- 1. Market Overview
- 2. Research Measurement
- 3. Revenue Forecasts
- 4. Competitive Structure
9. SPANISH IMMUNOHISTOCHEMISTRY DIAGNOSTICS MARKET
Forecast of the Spanish Immunohistochemistry Diagnostics Market
- 1. Market Overview
- 2. Research Measurement
- 3. Revenue Forecasts
- 4. Competitive Structure
10. BENELUX IMMUNOHISTOCHEMISTRY DIAGNOSTICS MARKET
Forecast of the Benelux Immunohistochemistry Diagnostics Market
- 1. Market Overview
- 2. Research Measurement
- 3. Revenue Forecasts
- 4. Competitive Structure
11. SCANDINAVIAN IMMUNOHISTOCHEMISTRY DIAGNOSTICS MARKET
Forecast of the Scandinavian Immunohistochemistry Diagnostics Market
- 1. Market Overview
- 2. Research Measurement
- 3. Revenue Forecasts
- 4. Competitive Structure
12. MARKET ENGINEERING STRATEGIC RECOMMENDATIONS
Strategic Recommendations
- 1. Strategic Recommendations
13. FROST & SULLIVAN AWARDS
Awards for the European Immunohistochemistry Diagnostics Market
- 1. Introduction
- 2. Product Innovation Award
- 3. Market Penetration Leadership Award
- 4. Market Leadership Award
14. DATABASE OF KEY INDUSTRY PARTICIPANTS
Database of Key Industry Participants
- 1. Key Industry Participants
15. DECISION SUPPORT DATABASES
Decision Support Databases
- 1. Decision Support Databases
